SCOPUS 정보 검색 플랫폼

Immunology

Volumn 104, Issue 1, 2001, Pages 1-7

Immunotherapy of melanoma

(2) Smith, Caroline a Cerundolo, Vincenzo a,b

a UNIVERSITY OF OXFORD (United Kingdom)

b UNIVERSITY OF OXFORD (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; DIFFERENTIATION ANTIGEN; FREUND ADJUVANT; GLUTAMYLVALYLASPARTYLPROLYLISOLEUCYLGLYCYLHISTIDYLLEUCYLTYROSINE; GLYCOPROTEIN GP 100; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; ISOLEUCYLMETHIONYLASPARTYLGLUTAMINYLVALYLPROLYLPHENYLALANYLSERYLTYROSINE; ISOLEUCYLTHREONYLASPARTYLGLUTAMINYLVALYLPROLYLPHENYLALANYLSERYLTYROSINE; KEYHOLE LIMPET HEMOCYANIN; MELAN A; MONOPHENOL MONOOXYGENASE; NONAPEPTIDE; PEPTIDE; PLASMID DNA; QS 21; RECOMBINANT DNA; RECOMBINANT VACCINE; TUMOR ANTIGEN; TUMOR PROTEIN; TYROSYLLEUCYLGLUTAMYLPROLYLGLYCYLPROLYLVALYLTHREONYLALANINE; TYROSYLLEUCYLGLUTAMYLPROLYLGLYCYLPROLYLVALYLTHREONYLVALINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ADOPTIVE IMMUNOTHERAPY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MONITORING; MELANOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS RECOMBINANT;

ANTIGENS, NEOPLASM; CANCER VACCINES; IMMUNOTHERAPY; MELANOMA; SKIN NEOPLASMS;

EID: 0034791644 PISSN: 00192805 EISSN: None Source Type: Journal
DOI: 10.1046/j.1365-2567.2001.01297.x Document Type: Review

Times cited : (23)

References (58)

1
- 0024316157
- Structure of the gene of tum-transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells
- (1989) Cell , vol.58 , pp. 293-303
- Lurquin, C.¹ Van Pel, A.² Mariame, B.³ De Plaen, E.⁴ Szikora, J.P.⁵ Janssens, C.⁶ Reddehase, M.J.⁷ Lejeune, J.⁸ Boon, T.⁹

2
- 0035095532
- Listing of human tumor antigens recognized by T cells
- (2001) Cancer Immunol Immunother , vol.50 , pp. 3-15
- Renkvist, N.¹ Castelli, C.² Robbins, P.F.³ Parmiani, G.A.⁴

3
- 0033103512
- Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes
- (1999) J Exp Med , vol.189 , pp. 767-778
- Chaux, P.¹ Vantomme, V.² Stroobant, V.³ Thielemans, K.⁴ Corthals, J.⁵ Luiten, R.⁶ Eggermont, A.M.⁷ Boon, T.⁸ Van der Bruggen, P.⁹

4
- 0034695886
- Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma
- (2000) J Exp Med , vol.191 , pp. 625-630
- Jager, E.¹ Jager, D.² Karbach, J.³ Chen, Y.T.⁴ Ritter, G.⁵ Nagata, Y.⁶ Gnjatic, S.⁷ Stockert, E.⁸ Arand, M.⁹ Old, L.J.¹⁰ Knuth, A.¹¹

5
- 0033577804
- Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells
- (1999) J Exp Med , vol.189 , pp. 1659-1668
- Wang, R.F.¹ Wang, X.² Rosenberg, S.A.³

6
- 0032476616
- Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
- (1998) J Exp Med , vol.188 , pp. 1641-1650
- Romero, P.¹ Dunbar, P.R.² Valmori, D.³ Pittet, M.⁴ Ogg, G.S.⁵ Rimoldi, D.⁶ Chen, J.L.⁷ Lienard, D.⁸ Cerottini, J.C.⁹ Cerundolo, V.¹⁰

7
- 0033564637
- Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
- (1999) J Immunol , vol.162 , pp. 6959-6962
- Dunbar, P.R.¹ Chen, J.L.² Chao, D.³ Rust, N.⁴ Teisserenc, H.⁵ Ogg, G.S.⁶ Romero, P.⁷ Weynants, P.⁸ Cerundolo, V.⁹

8
- 0034544532
- A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
- (2000) J Immunol , vol.165 , pp. 6644-6652
- Dunbar, P.R.¹ Smith, C.L.² Chao, D.³ Salio, M.⁴ Shepherd, D.⁵ Mirza, F.⁶ Lipp, M.⁷ Lanzavecchia, A.⁸ Sallusto, F.⁹ Evans, A.¹⁰ Russell-Jones, R.¹¹ Harris, A.L.¹² Cerundolo, V.¹³

9
- 0026322151
- A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
- (1991) Science , vol.254 , pp. 1643-1647
- Van der Bruggen, P.¹ Traversari, C.² Chomez, P.³ Lurquin, C.⁴ De Plaen, E.⁵ Van den Eynde, B.⁶ Knuth, A.⁷ Boon, T.⁸

10
- 0033591429
- Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
- (1999) Science , vol.284 , pp. 1351-1354
- Wang, R.F.¹ Wang, X.² Atwood, A.C.³ Topalian, S.L.⁴ Rosenberg, S.A.⁵

11
- 0344351839
- Serological analysis of human tumor antigens: Molecular definition and implications
- (1997) Mol Med Today , vol.3 , pp. 342-349
- Tureci, O.¹ Sahin, U.² Pfreundschuh, M.³

12
- 0032499710
- Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
- (1998) Proc Natl Acad Sci USA , vol.95 , pp. 6919-6923
- Chen, Y.T.¹ Gure, A.O.² Tsang, S.³ Stockert, E.⁴ Jager, E.⁵ Knuth, A.⁶ Old, L.J.⁷

13
- 0034039974
- MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
- (2000) Int J Cancer , vol.87 , pp. 55-60
- Lucas, S.¹ De Plaen, E.² Boon, T.³

14
- 0028304337
- Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
- (1994) Science , vol.264 , pp. 716-719
- Cox, A.L.¹ Skipper, J.² Chen, Y.³ Henderson, R.A.⁴ Darrow, T.L.⁵ Shabanowitz, J.⁶ Engelhard, V.H.⁷ Hunt, D.F.⁸ Slingluff C.L., Jr.⁹

15
- 0029957792
- The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
- (1996) Proc Natl Acad Sci USA , vol.93 , pp. 7149-7153
- De Smet, C.¹ De Backer, O.² Faraoni, I.³ Lurquin, C.⁴ Brasseur, F.⁵ Boon, T.⁶

16
- 0028050181
- Structure, chromosomal localization, and expression of 12 genes of the MAGE family
- (1994) Immunogenetics , vol.40 , pp. 360-369
- De Plaen, E.¹ Arden, K.² Traversari, C.³ Gaforio, J.J.⁴ Szikora, J.P.⁵ De Smet, C.⁶ Brasseur, F.⁷ Van der Bruggen, P.⁸ Lethe, B.⁹ Lurquin, C.¹⁰

17
- 0029085917
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
- (1995) J Exp Med , vol.182 , pp. 689-698
- Van den Eynde, B.¹ Peeters, O.² De Backer, O.³ Gaugler, B.⁴ Lucas, S.⁵ Boon, T.⁶

18
- 0028952240
- BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
- (1995) Immunity , vol.2 , pp. 167-175
- Boel, P.¹ Wildmann, C.² Sensi, M.L.³ Brasseur, R.⁴ Renauld, J.C.⁵ Coulie, P.⁶ Boon, T.⁷ Van der Bruggen, P.⁸

19
- 0033168930
- Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
- (1999) Cancer Res , vol.59 , pp. 3157-3165
- De Backer, O.¹ Arden, K.C.² Boretti, M.³ Vantomme, V.⁴ De Smet, C.⁵ Czekay, S.⁶ Viars, C.S.⁷ De Plaen, E.⁸ Brasseur, F.⁹ Chomez, P.¹⁰ Van den Eynde, B.¹¹ Boon, T.¹² Van der Bruggen, P.¹³

20
- 12644276375
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
- (1997) Proc Natl Acad Sci USA , vol.94 , pp. 1914-1918
- Chen, Y.T.¹ Scanlan, M.J.² Sahin, U.³ Tureci, O.⁴ Gure, A.O.⁵ Tsang, S.⁶ Williamson, B.⁷ Stockert, E.⁸ Pfreundschuh, M.⁹ Old, L.J.¹⁰

21
- 0033595632
- Humoral immune responses of cancer patients against 'cancer-testis' antigen NY-ESO-1: Correlation with clinical events
- (1999) Int J Cancer , vol.84 , pp. 506-510
- Jager, E.¹ Stockert, E.² Zidianakis, Z.³ Chen, Y.T.⁴ Karbach, J.⁵ Jager, D.⁶ Arand, M.⁷ Ritter, G.⁸ Old, L.J.⁹ Knuth, A.¹⁰

22
- 12944265542
- Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
- (2000) Proc Natl Acad Sci USA , vol.97 , pp. 10917-10922
- Gnjatic, S.¹ Nagata, Y.² Jager, E.³ Stockert, E.⁴ Shankara, S.⁵ Roberts, B.L.⁶ Mazzara, G.P.⁷ Lee, S.Y.⁸ Dunbar, P.R.⁹ Dupont, B.¹⁰ Cerundolo, V.¹¹ Ritter, G.¹² Chen, Y.T.¹³ Knuth, A.¹⁴ Old, L.J.¹⁵

23
- 0032819985
- High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
- (1999) J Exp Med , vol.190 , pp. 705-715
- Pittet, M.J.¹ Valmori, D.² Dunbar, P.R.³ Speiser, D.E.⁴ Lienard, D.⁵ Lejeune, F.⁶ Fleischhauer, K.⁷ Cerundolo, V.⁸ Cerottini, J.C.⁹ Romero, P.¹⁰

24
- 0032555951
- Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
- (1998) J Exp Med , vol.188 , pp. 1005-1016
- Lupetti, R.¹ Pisarra, P.² Verrecchia, A.³ Farina, C.⁴ Nicolini, G.⁵ Anichini, A.⁶ Bordignon, C.⁷ Sensi, M.⁸ Parmiani, G.⁹ Traversari, C.¹⁰

25
- 0034600786
- HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
- (2000) J Exp Med , vol.192 , pp. 63-75
- Appay, V.¹ Nixon, D.F.² Donahoe, S.M.³ Gillespie, G.M.⁴ Dong, T.⁵ King, A.⁶ Ogg, G.S.⁷ Spiegel, H.M.⁸ Conlon, C.⁹ Spina, C.A.¹⁰ Havlir, D.V.¹¹ Richman, D.D.¹² Waters, A.¹³ Easterbrook, P.¹⁴ McMichael, A.J.¹⁵ Rowland-Jones, S.L.¹⁶

26
- 0029743737
- Phenotypic analysis of antigen-specific T lymphocytes
- (1996) Science , vol.274 , pp. 94-96
- Altman, J.D.¹ Moss, P.A.² Goulder, P.J.³ Barouch, D.H.⁴ McHeyzer-Williams, M.G.⁵ Bell, J.I.⁶ McMichael, A.J.⁷ Davis, M.M.⁸

27
- 0033056073
- Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
- (1999) Nat Med , vol.5 , pp. 677-685
- Lee, P.P.¹ Yee, C.² Savage, P.A.³ Fong, L.⁴ Brockstedt, D.⁵ Weber, J.S.⁶ Johnson, D.⁷ Swetter, S.⁸ Thompson, J.⁹ Greenberg, P.D.¹⁰ Roederer, M.¹¹ Davis, M.M.¹²

28
- 0024510298
- Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer
- (1989) Lancet , vol.1 , pp. 577-580
- Kradin, R.L.¹ Kurnick, J.T.² Lazarus, D.S.³ Preffer, F.I.⁴ Dubinett, S.M.⁵ Pinto, C.E.⁶ Gifford, J.⁷ Davidson, E.⁸ Grove, B.⁹ Callahan, R.J.¹⁰

29
- 0023934650
- Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study
- (1988) J Clin Oncol , vol.6 , pp. 839-853
- Topalian, S.L.¹ Solomon, D.² Avis, F.P.³ Chang, A.E.⁴ Freerksen, D.L.⁵ Linehan, W.M.⁶ Lotze, M.T.⁷ Robertson, C.N.⁸ Seipp, C.A.⁹ Simon, P.¹⁰

30
- 0024166189
- Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report
- (1988) N Engl J Med , vol.319 , pp. 1676-1680
- Rosenberg, S.A.¹ Packard, B.S.² Aebersold, P.M.³ Solomon, D.⁴ Topalian, S.L.⁵ Toy, S.T.⁶ Simon, P.⁷ Lotze, M.T.⁸ Yang, J.C.⁹ Seipp, C.A.¹⁰

31
- 0028031582
- Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
- (1994) J Natl Cancer Inst , vol.86 , pp. 1159-1166
- Rosenberg, S.A.¹ Yannelli, J.R.² Yang, J.C.³ Topalian, S.L.⁴ Schwartzentruber, D.J.⁵ Weber, J.S.⁶ Parkinson, D.R.⁷ Seipp, C.A.⁸ Einhorn, J.H.⁹ White, D.E.¹⁰

32
- 0034606276
- Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo
- (2000) J Exp Med , vol.192 , pp. 1637-1644
- Yee, C.¹ Thompson, J.A.² Roche, P.³ Byrd, D.R.⁴ Lee, P.P.⁵ Piepkorn, M.⁶ Kenyon, K.⁷ Davis, M.M.⁸ Riddell, S.R.⁹ Greenberg, P.D.¹⁰

33
- 0027990846
- Donor T cells to treat EBV-associated lymphoma
- (1994) N Engl J Med , vol.331 , pp. 679-680
- Heslop, H.E.¹ Brenner, M.K.² Rooney, C.M.³

34
- 0032170108
- Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
- (1998) Blood , vol.92 , pp. 1549-1555
- Rooney, C.M.¹ Smith, C.A.² Ng, C.Y.³ Loftin, S.K.⁴ Sixbey, J.W.⁵ Gan, Y.⁶ Srivastava, D.K.⁷ Bowman, L.C.⁸ Krance, R.A.⁹ Brenner, M.K.¹⁰ Heslop, H.E.¹¹

35
- 0031890206
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- (1998) Nat Med , vol.4 , pp. 321-327
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Restifo, N.P.⁷ Dudley, M.E.⁸ Schwarz, S.L.⁹ Spiess, P.J.¹⁰ Wunderlich, J.R.¹¹ Parkhurst, M.R.¹² Kawakami, Y.¹³ Seipp, C.A.¹⁴ Einhorn, J.H.¹⁵ White, D.E.¹⁶

36
- 0041485051
- Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo
- (1996) Int J Cancer , vol.67 , pp. 54-62
- Jager, E.¹ Ringhoffer, M.² Dienes, H.P.³ Arand, M.⁴ Karbach, J.⁵ Jager, D.⁶ Ilsemann, C.⁷ Hagedorn, M.⁸ Oesch, F.⁹ Knuth, A.¹⁰

37
- 0033579934
- Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
- (1999) Int J Cancer , vol.80 , pp. 219-230
- Marchand, M.¹ Van Baren, N.² Weynants, P.³ Brichard, V.⁴ Dreno, B.⁵ Tessier, M.H.⁶ Rankin, E.⁷ Parmiani, G.⁸ Arienti, F.⁹ Humblet, Y.¹⁰ Bourlond, A.¹¹ Vanwijck, R.¹² Lienard, D.¹³ Beauduin, M.¹⁴ Dietrich, P.Y.¹⁵ Russo, V.¹⁶ Kerger, J.¹⁷ Masucci, G.¹⁸ Jager, E.¹⁹ De Greve, J.²⁰ more..

38
- 3242680077
- Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
- (2000) Proc Natl Acad Sci USA , vol.97 , pp. 12198-12203
- Jager, E.¹ Gnjatic, S.² Nagata, Y.³ Stockert, E.⁴ Jager, D.⁵ Karbach, J.⁶ Neumann, A.⁷ Rieckenberg, J.⁸ Chen, Y.T.⁹ Ritter, G.¹⁰ Hoffman, E.¹¹ Arand, M.¹² Old, L.J.¹³ Knuth, A.¹⁴

39
- 0029837404
- Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides
- (1996) Cancer Res , vol.56 , pp. 4749-4757
- Salgaller, M.L.¹ Marincola, F.M.² Cormier, J.N.³ Rosenberg, S.A.⁴

40
- 0031716189
- Immunization of patients with melanoma peptide vaccines: Immunologic assessment using the ELISPOT assay
- (1998) Cancer J Sci Am , vol.4 , pp. 316-323
- Pass, H.A.¹ Schwarz, S.L.² Wunderlich, J.R.³ Rosenberg, S.A.⁴

41
- 0033178581
- Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine
- (1999) J Immunol , vol.163 , pp. 1690-1695
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Restifo, N.P.⁷ Sznol, M.⁸ Schwarz, S.L.⁹ Spiess, P.J.¹⁰ Wunderlich, J.R.¹¹ Seipp, C.A.¹² Einhorn, J.H.¹³ Rogers-Freezer, L.¹⁴ White, D.E.¹⁵

42
- 0030996710
- Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
- (1997) Cancer J Sci Am , vol.3 , pp. 37-44
- Cormier, J.N.¹ Salgaller, M.L.² Prevette, T.³ Barracchini, K.C.⁴ Rivoltini, L.⁵ Restifo, N.P.⁶ Rosenberg, S.A.⁷ Marincola, F.M.⁸

43
- 0032724112
- Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma
- (1999) Clin Cancer Res , vol.5 , pp. 2756-2765
- Wang, F.¹ Bade, E.² Kuniyoshi, C.³ Spears, L.⁴ Jeffery, G.⁵ Marty, V.⁶ Groshen, S.⁷ Weber, J.⁸

44
- 0034255724
- Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
- (2000) Int J Cancer , vol.87 , pp. 391-398
- Lewis, J.J.¹ Janetzki, S.² Schaed, S.³ Panageas, K.S.⁴ Wang, S.⁵ Williams, L.⁶ Meyers, M.⁷ Butterworth, L.⁸ Livingston, P.O.⁹ Chapman, P.B.¹⁰ Houghton, A.N.¹¹

45
- 0034064242
- Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma
- (2000) J Immunother , vol.23 , pp. 275-281
- Scheibenbogen, C.¹ Schmittel, A.² Keilholz, U.³ Allgauer, T.⁴ Hofmann, U.⁵ Max, R.⁶ Thiel, E.⁷ Schadendorf, D.⁸

46
- 0029997742
- Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
- (1996) Int J Cancer , vol.66 , pp. 162-169
- Jaeger, E.¹ Bernhard, H.² Romero, P.³ Ringhoffer, M.⁴ Arand, M.⁵ Karbach, J.⁶ Ilsemann, C.⁷ Hagedorn, M.⁸ Knuth, A.⁹

47
- 0343729873
- Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides
- (2000) Int J Cancer , vol.86 , pp. 538-547
- Jager, E.¹ Maeurer, M.² Hohn, H.³ Karbach, J.⁴ Jager, D.⁵ Zidianakis, Z.⁶ Bakhshandeh-Bath, A.⁷ Orth, J.⁸ Neukirch, C.⁹ Necker, A.¹⁰ Reichert, T.E.¹¹ Knuth, A.¹²

48
- 0028289244
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
- (1994) J Exp Med , vol.179 , pp. 1109-1118
- Sallusto, F.¹ Lanzavecchia, A.²

49
- 0035862333
- Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
- (2001) J Exp Med , vol.193 , pp. 233-238
- Dhodapkar, M.V.¹ Steinman, R.M.² Krasovsky, J.³ Munz, C.⁴ Bhardwaj, N.⁵

50
- 0034613767
- Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
- (2000) J Exp Med , vol.192 , pp. 1213-1222
- Jonuleit, H.¹ Schmitt, E.² Schuler, G.³ Knop, J.⁴ Enk, A.H.⁵

51
- 0035862336
- Differentiation of T regulatory cells by immature dendritic cells
- (2001) J Exp Med , vol.193
- Roncarolo, M.G.¹ Levings, M.K.² Traversari, C.³

52
- 0034332994
- A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
- (2000) J Immunol Methods , vol.245 , pp. 15-29
- Feuerstein, B.¹ Berger, T.G.² Maczek, C.³ Roder, C.⁴ Schreiner, D.⁵ Hirsch, U.⁶ Haendle, I.⁷ Leisgang, W.⁸ GlaSeries, A.⁹ Kuss, O.¹⁰ Diepgen, T.L.¹¹ Schuler, G.¹² Schuler-Thurner, B.¹³

53
- 0033405438
- Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
- (1999) J Exp Med , vol.190 , pp. 1669-1678
- Thurner, B.¹ Haendle, I.² Roder, C.³ Dieckmann, D.⁴ Keikavoussi, P.⁵ Jonuleit, H.⁶ Bender, A.⁷ Maczek, C.⁸ Schreiner, D.⁹ Von den Driesch, P.¹⁰ Brocker, E.B.¹¹ Steinman, R.M.¹² Enk, A.¹³ Kampgen, E.¹⁴ Schuler, G.¹⁵

54
- 0031941423
- Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
- (1998) Nat Med , vol.4 , pp. 328-332
- Nestle, F.O.¹ Alijagic, S.² Gilliet, M.³ Sun, Y.⁴ Grabbe, S.⁵ Dummer, R.⁶ Burg, G.⁷ Schadendorf, D.⁸

55
- 0029820526
- DNA-based immunization by in vivo transfection of dendritic cells
- (1996) Nat Med , vol.2 , pp. 1122-1128
- Condon, C.¹ Watkins, S.C.² Celluzzi, C.M.³ Thompson, K.⁴ Falo L.D., Jr.⁵

56
- 0030022796
- Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
- (1996) J Immunol , vol.156 , pp. 238-245
- Irvine, K.R.¹ Rao, J.B.² Rosenberg, S.A.³ Restifo, N.P.⁴

57
- 0032033577
- Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
- (1998) Vaccine , vol.16 , pp. 439-445
- Hanke, T.¹ Blanchard, T.J.² Schneider, J.³ Hannan, C.M.⁴ Becker, M.⁵ Gilbert, S.C.⁶ Hill, A.V.⁷ Smith, G.L.⁸ McMichael, A.⁹

58
- 0031924077
- Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
- (1998) Nat Med , vol.4 , pp. 397-402
- Schneider, J.¹ Gilbert, S.C.² Blanchard, T.J.³ Hanke, T.⁴ Robson, K.J.⁵ Hannan, C.M.⁶ Becker, M.⁷ Sinden, R.⁸ Smith, G.L.⁹ Hill, A.V.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.